Google's new channel performance view for PMax gives advertisers a timeline breakdown of what's working across Search, ...

The mission is expected to last about 10 days, with the crew reaching the moon's vicinity on around day five or six before ...

Google has announced that it is bringing massive update to its Workspace suite, officially supercharging its Workspace apps – Docs, Sheets, Slides and Drive – with Gemini AI-powered features which ...

Google is rolling out a batch of Gemini updates across its Workspace apps that give the AI assistant the ability to generate first drafts in Docs, build entire spreadsheets in Sheets, design ...

A wave of Workspace updates puts Gemini inside Docs, Sheets, Slides, and Drive, with a benchmark result Google is happy to shout about. The blinking cursor is Google’s enemy. Every time a Workspace ...

Google announced on Tuesday that it’s bringing a slew of new Gemini-powered AI capabilities to Docs, Sheets, Slides, and Drive. The new features let users do things like quickly generate fully ...

Google is rolling out new AI features designed to quickly flesh out Google Docs, Sheets, and Slides using data from the web and your existing Google files. The overall aim is to eliminate much of the ...

The GRIDTIDE backdoor concealed its traffic within routine spreadsheet activity for years before Google shut down the operation last week. Google has disrupted a China-linked espionage group that used ...

Google disrupted a Chinese-linked hacking group that breached at least 53 organizations across 42 countries, the company said Wednesday.

Google Gemini cheat sheet with key features, how the models work, where it’s available on web, Android, iOS, Workspace, plus pricing and setup steps. Generated with Google Gemini. Google Gemini is ...

Editorial Note: Talk Android may contain affiliate links on some articles. If you make a purchase through these links, we will earn a commission at no extra cost to you. Learn more. MileageWise has ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.